Detection of potential drug-drug interactions among ovarian cancer patients in a tertiary care teaching hospital in South India- A retrospective approach

Background: Potential drug-drug interactions (pDDIs) can alter therapeutic efficacy, involve adverse reactions, and generate novel responses not elicited when either agent is used alone. pDDIs can contribute to morbidity and mortality. Cancer patients are at high risk of pDDIs because of polypharmac...

Full description

Bibliographic Details
Main Authors: Kala Bahadur Rawal, Uday Venkat Mateti, Vijith Shetty, M.K. Unnikrishnan, C.S. Shastry
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Clinical Epidemiology and Global Health
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213398423001203
_version_ 1797754063404662784
author Kala Bahadur Rawal
Uday Venkat Mateti
Vijith Shetty
M.K. Unnikrishnan
C.S. Shastry
author_facet Kala Bahadur Rawal
Uday Venkat Mateti
Vijith Shetty
M.K. Unnikrishnan
C.S. Shastry
author_sort Kala Bahadur Rawal
collection DOAJ
description Background: Potential drug-drug interactions (pDDIs) can alter therapeutic efficacy, involve adverse reactions, and generate novel responses not elicited when either agent is used alone. pDDIs can contribute to morbidity and mortality. Cancer patients are at high risk of pDDIs because of polypharmacy necessitated by chemotherapy, hormone therapy, and supportive care medications. Our study was designed to quantify the prevalence of pDDIs among ovarian cancer patients in a tertiary care teaching hospital in South India. Materials and methods: We retrospectively analysed data gathered over two years on ovarian cancer patients 18 years and above undergoing antineoplastic therapy (other than radiation and surgery). The patient's treatment charts were reviewed, and the drugs prescribed were analysed for the possible pDDIs using UpToDate software (Lexicomp® database). Results: A total of 354 pDDIs were detected among 92 patients included in the study, with (56.5%; n = 200) experiencing moderate severity. (52.3%; n = 158) pDDIs fell under pDDIs risk category D, and pDDIs reliability rating was 'fair' in (76.8%; n = 272). Most commonly observed pDDIs for neoplastic agents occurred between paclitaxel and carboplatin (16.4%; n = 58) and between ondansetron and domperidone under supportive therapy (20.9%; n = 74). Polypharmacy accounted for 100% of inpatient prescriptions and 50% of prescriptions at discharge. Conclusion: Ovarian cancer poses a significant risk of pDDIs and requires an interdisciplinary vigilance policy to prevent, minimize, and manage unwanted effects of pDDIs.
first_indexed 2024-03-12T17:27:02Z
format Article
id doaj.art-ede597d38ded449d954d08a4814580df
institution Directory Open Access Journal
issn 2213-3984
language English
last_indexed 2024-03-12T17:27:02Z
publishDate 2023-07-01
publisher Elsevier
record_format Article
series Clinical Epidemiology and Global Health
spelling doaj.art-ede597d38ded449d954d08a4814580df2023-08-05T05:15:56ZengElsevierClinical Epidemiology and Global Health2213-39842023-07-0122101333Detection of potential drug-drug interactions among ovarian cancer patients in a tertiary care teaching hospital in South India- A retrospective approachKala Bahadur Rawal0Uday Venkat Mateti1Vijith Shetty2M.K. Unnikrishnan3C.S. Shastry4Nitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences, Department of Pharmacy Practice, Mangaluru, Karnataka, IndiaNitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences, Department of Pharmacy Practice, Mangaluru, Karnataka, India; Corresponding author.Nitte (Deemed to be University), KS Hegde Medical Academy (KSHEMA), Justice KS Hegde Charitable Hospital, Department of Medical Oncology, Mangaluru, Karnataka, IndiaNitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences, Department of Pharmacy Practice, Mangaluru, Karnataka, IndiaNitte (Deemed to be University), NGSM Institute of Pharmaceutical Sciences, Department of Pharmacy Practice, Mangaluru, Karnataka, IndiaBackground: Potential drug-drug interactions (pDDIs) can alter therapeutic efficacy, involve adverse reactions, and generate novel responses not elicited when either agent is used alone. pDDIs can contribute to morbidity and mortality. Cancer patients are at high risk of pDDIs because of polypharmacy necessitated by chemotherapy, hormone therapy, and supportive care medications. Our study was designed to quantify the prevalence of pDDIs among ovarian cancer patients in a tertiary care teaching hospital in South India. Materials and methods: We retrospectively analysed data gathered over two years on ovarian cancer patients 18 years and above undergoing antineoplastic therapy (other than radiation and surgery). The patient's treatment charts were reviewed, and the drugs prescribed were analysed for the possible pDDIs using UpToDate software (Lexicomp® database). Results: A total of 354 pDDIs were detected among 92 patients included in the study, with (56.5%; n = 200) experiencing moderate severity. (52.3%; n = 158) pDDIs fell under pDDIs risk category D, and pDDIs reliability rating was 'fair' in (76.8%; n = 272). Most commonly observed pDDIs for neoplastic agents occurred between paclitaxel and carboplatin (16.4%; n = 58) and between ondansetron and domperidone under supportive therapy (20.9%; n = 74). Polypharmacy accounted for 100% of inpatient prescriptions and 50% of prescriptions at discharge. Conclusion: Ovarian cancer poses a significant risk of pDDIs and requires an interdisciplinary vigilance policy to prevent, minimize, and manage unwanted effects of pDDIs.http://www.sciencedirect.com/science/article/pii/S2213398423001203Drug-interactionsDrug safetyGynecological neoplasmIndiaOvary cancers
spellingShingle Kala Bahadur Rawal
Uday Venkat Mateti
Vijith Shetty
M.K. Unnikrishnan
C.S. Shastry
Detection of potential drug-drug interactions among ovarian cancer patients in a tertiary care teaching hospital in South India- A retrospective approach
Clinical Epidemiology and Global Health
Drug-interactions
Drug safety
Gynecological neoplasm
India
Ovary cancers
title Detection of potential drug-drug interactions among ovarian cancer patients in a tertiary care teaching hospital in South India- A retrospective approach
title_full Detection of potential drug-drug interactions among ovarian cancer patients in a tertiary care teaching hospital in South India- A retrospective approach
title_fullStr Detection of potential drug-drug interactions among ovarian cancer patients in a tertiary care teaching hospital in South India- A retrospective approach
title_full_unstemmed Detection of potential drug-drug interactions among ovarian cancer patients in a tertiary care teaching hospital in South India- A retrospective approach
title_short Detection of potential drug-drug interactions among ovarian cancer patients in a tertiary care teaching hospital in South India- A retrospective approach
title_sort detection of potential drug drug interactions among ovarian cancer patients in a tertiary care teaching hospital in south india a retrospective approach
topic Drug-interactions
Drug safety
Gynecological neoplasm
India
Ovary cancers
url http://www.sciencedirect.com/science/article/pii/S2213398423001203
work_keys_str_mv AT kalabahadurrawal detectionofpotentialdrugdruginteractionsamongovariancancerpatientsinatertiarycareteachinghospitalinsouthindiaaretrospectiveapproach
AT udayvenkatmateti detectionofpotentialdrugdruginteractionsamongovariancancerpatientsinatertiarycareteachinghospitalinsouthindiaaretrospectiveapproach
AT vijithshetty detectionofpotentialdrugdruginteractionsamongovariancancerpatientsinatertiarycareteachinghospitalinsouthindiaaretrospectiveapproach
AT mkunnikrishnan detectionofpotentialdrugdruginteractionsamongovariancancerpatientsinatertiarycareteachinghospitalinsouthindiaaretrospectiveapproach
AT csshastry detectionofpotentialdrugdruginteractionsamongovariancancerpatientsinatertiarycareteachinghospitalinsouthindiaaretrospectiveapproach